- Poster presentation
- Open access
- Published:
Role of Dopamine β Hydroxylase (DBH) in Parkinson's disease patients of Indian population
Molecular Cytogenetics volume 7, Article number: P122 (2014)
Background
Parkinson's disease is a neurodegenerative disease affecting at least 1% of the population over age of 55. It is characterized by selective loss of dopaminergic neurons in substantia nigra pars compacta and the appearance of intracellular inclusions termed Lewy bodies. As the age progresses, neurons in the other regions of brain are also degenerated. Depletion of brain dopamine initiates aberrant motor activities including rest tremor, rigidity, bradykinesia, postural instability. Apart from motor symptoms, cognitive impairments, like depression, psychiatric illness, and decreased mental ability are also observed in the patients. Genetic and non-genetic components are believed to govern the pathogenesis of PD. Genes in dopaminergic pathway & also dopamine synthesis, storage, binding, metabolism are needed to be studied which seem to be major determinants conferring differential risk of developing PD.
Methods
In this study, three reported SNPs, rs1611115 (T>C), rs1108580 (A>G), rs129882 (C>T) of DBH have been analyzed. For rs1611115 (T>C), 229 patients & 252 controls have been screened. A total of 298 patients & 276 control samples have been analyzed for rs129882 (C>T). A total of 378 patients & 253 control samples have been analyzed for rs 1108580 (A>G). All these SNPs were screened by PCR , sequencing and/or RFLP analysis. Also, DBH activity has been measured in plasma isolated from patients’ blood.
Results
For rs1611115 (T>C), the minor allele T is over represented in control samples & pose a protection (p=0.043, OR=0.731, 95% CI=0.731 (0.538-0.847) for this disease. No significant association has been found for rs1108580 (A>G). For rs129882 (C>T), the minor allele T is over represented in patient pool & confers a risk (p=0.036, OR=1.322, 95% CI=1.012-1.727) for this disease. DBH activity has been measured in plasma isolated from patients’ blood. A correlation has been found between plasma DBH activity & rs1611115.
Conclusion
This study suggests that DBH might have a role in susceptibility of developing Parkinson’s disease.
Acknowledgements
This study is funded by the Department of Science & Technology (DST), Goverment of India, University Grant Commission (UGC), Goverment of India.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
Open Access This article is published under license to BioMed Central Ltd. This is an Open Access article is distributed under the terms of the Creative Commons Attribution License ( https://creativecommons.org/licenses/by/2.0 ), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly credited. The Creative Commons Public Domain Dedication waiver ( https://creativecommons.org/publicdomain/zero/1.0/ ) applies to the data made available in this article, unless otherwise stated.
About this article
Cite this article
Ghosh, A., Biswas, A., Sadhukhan, T. et al. Role of Dopamine β Hydroxylase (DBH) in Parkinson's disease patients of Indian population. Mol Cytogenet 7 (Suppl 1), P122 (2014). https://doi.org/10.1186/1755-8166-7-S1-P122
Published:
DOI: https://doi.org/10.1186/1755-8166-7-S1-P122